Author/Authors :
Liu، نويسنده , , Jian-Ying and Shu، نويسنده , , Qiang and Gao، نويسنده , , Lifen and Hou، نويسنده , , Nan and Zhao، نويسنده , , Di and Liu، نويسنده , , Xiao and Zhang، نويسنده , , Xiaoning and Xu، نويسنده , , Liyun and Yue، نويسنده , , Xuetian and Zhu، نويسنده , , Faliang and Guo، نويسنده , , Chun and Liang، نويسنده , , Xiaohong and Ma، نويسنده , , Chunhong، نويسنده ,
Abstract :
Tim-3 has been reported as an important regulatory molecule and plays a pivotal role in several autoimmunity diseases. Here, we demonstrated the increased expression of Tim-3 on peripheral CD4+ T, CD8+ T, NKT cells and monocytes from RA patients compared to those from healthy controls. Percentage of Tim-3+ cells in peripheral blood mononuclear cells (PBMCs) showed an inverse correlation with disease activity score 28 (DAS28) and plasma TNF-α level. Similar negative correlations were found between disease activity and Tim-3 levels on CD4+ T, CD8+ T and NKT cells. Consistently, Tim-3 expression on CD3+ T cells was further increased in patients with disease remission after treatment. Tim-3 expression on CD8+ T and NKT cells negatively correlates with plasma TNF-α. Our results suggest that Tim-3 might participate in the proceeding of RA by its negative regulation on various T cell subsets. Tim-3 might be a potential new marker for assessing severity of RA.
Keywords :
rheumatoid arthritis , Disease activity score 28 , TNF-? , TIM-3